drugset / Trial / NCT04531527

Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human Subjects

NCT04531527

Phase 3 Completed 32 enrolled Bayer
NaSingle-groupOpen-labelTreatment

Summary

In this study researchers want to gather information about the potential of Antifungal Cream V61-044 containing Trolamine to produce a phototoxic reaction on the skin. A phototoxic reaction is an irritant reaction of the skin to ultra violet light. In order to find this out the study drug will be applied to the skin of healthy human subjects. By using a solar simulator to generate a UV spectrum similar to that of sunlight the potential of the study drug to produce a superficial reddening of the skin will be measured.

Timeline

Start
2013-06-24
Primary completion
2013-06-28
Completion
2013-06-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Butenafine Small molecule 1 % Topical

Indications